fashion -WSS

fashion

author：leisure time 2025-10-01 02:14:53 - browse：959

Julia Rendleman/Getty Images for Eventive Marketing

Health insurer Cigna is paying more than $172 million to settle allegations that it committed fraud by knowingly submitting inaccurate diagnoses of its Medicare Advantage members, the company and Department of Justice announced Saturday.

The settlement stems from a wide-ranging government investigation into the coding practices of Medicare Advantage insurers, as well as a specific whistleblower lawsuit against Cigna that the DOJ joined last year.

That lawsuit alleged Cigna’s home visit program “regularly generated false and invalid diagnosis codes for certain serious, complex conditions that cannot be reliably diagnosed in a home setting and without extensive diagnostic testing or imaging,” the DOJ said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Clinic falsely told dozens they had Alzheimer's, suits say

focus

WSS

What Henrietta Lacks's story taught me about my role as a doctor

Galapagos to make CAR

Galapagos to make CAR

WuXi Biologics beefs up its lobbying operation

Galapagos to make CAR

Novartis develops a rapidly manufactured CAR

entertainment

fashion

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

WuXi Biologics execs register to lobby as Congress comes for the company

As demand for Covid shots wanes, Moderna seeks its next success

Doctors have an ethical obligation to be advocates

As demand for Covid shots wanes, Moderna seeks its next success

WuXi Biologics execs register to lobby as Congress comes for the company

Moonlake's readout produced a cash windfall. Risks remain

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

BioMarin wins approval for gene therapy to treat hemophilia A

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

hotspot

Abbott's new stent may help patients with peripheral artery disease

ALS treatment from Biogen, Ionis fails in study

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

FAMU bans football players from facility after release of rap video shot in team's locker room

Where does female orgasm come from? Scientists think they know

Oak Street deal isn't the answer to health care's woes

hotspot

explore

focus

explore